Drug intelligence / Profile preview

physalis angulata extract

Development stage
Phase 2
Lead developer
Chemyunion
Modality
Small Molecules
Administration
Topical
01

Overview

*Physalis angulata* extract is a botanical substance derived from the Cutleaf Groundcherry plant, highly valued in dermatology for its concentration of **physalins**, which are naturally occurring secosteroids. It exhibits potent anti-inflammatory, antioxidant, and skin-soothing properties, often marketed as having a "corticosteroid-like" efficacy without the side effects associated with synthetic steroids, such as skin thinning or atrophy. The extract works by modulating the production of inflammatory mediators, specifically inhibiting the **NF-κB** signaling pathway and reducing the levels of pro-inflammatory cytokines like **TNF-α** and **IL-6**. It is primarily utilized in topical formulations to promote wound healing, accelerate re-epithelialization, and treat conditions characterized by erythema and skin sensitivity. It has been investigated in combination products (such as Ready Medical Post Treatment) to improve recovery after surgical procedures like split-thickness skin grafting.

Brand names
Physavie
Other names
Cutleaf groundcherry extractCamapu extractPhysalis angulata L. extract
02

Targets

IL-6 (Interleukin 6)NOS2 (Nitric Oxide Synthase 2)NF-κBTNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on physalis angulata extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on physalis angulata extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call